EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma

Haruhiko Yamazaki iD, Kiminori Sugino iD, Ryohei Katoh, Miho Kawaida, Kenichi Matsuzu, Wataru Kitagawa, Aya Saito, Koichi Ito

Journal of the Endocrine Society · 03.06.2026 · 10 (7)

DOI: 10.1210/jendso/bvag120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 21.05.2026. Verfasst von Haruhiko Yamazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Detailed studies considering the distinct types of non-papillary follicular cell–derived thyroid carcinoma in terms of radioactive iodine (RAI) avidity are limited.

Objective

This study aimed to investigate clinicopathological characteristics, relationship between histopathological findings, including solid/trabecular/insular (STI) components and RAI treatment (RAIT), in patients with non-papillary follicular cell–derived thyroid carcinoma.

Methods

This study included 114 patients with non-papillary follicular cell–derived thyroid carcinoma who underwent first RAIT between January 2005 and August 2025.

Results

Of the 114 patients, 5 (4%) were minimally invasive follicular thyroid carcinoma (MI-FTC), 41 (36%) were encapsulated angio-invasive FTC (EA-FTC), 23 (20%) were widely invasive FTC (WI-FTC), 22 (19%) were differentiated high-grade thyroid carcinoma (DHGTC), 21 (18%) were poorly differentiated thyroid carcinoma (PDTC), and 2 (2%) were others, respectively. The median percentages of STI component was 40% (range, 0%-10%) in all patients, 5% (range, 0%-50%) in MI-FTC, 30% (range, 0%-100%) in EA-FTC, 30% (range, 0%-100%) in WI-FTC, 28% (range, 5%-70%) in DHGTC, and 70% (range, 50%-100%) in PDTC, respectively. Among the 114 patients, the rate of RAI avidity was 60% (95% CI, 49%-71%) (47/78) in lung, 89% (95% CI, 79%-96%) (59/66) was in bone, 100% (13/13) in lymph node, and 100% (3/3) in other sites, respectively.

Conclusion

RAI avidity was relatively high in non-papillary follicular cell–derived thyroid carcinoma, regardless of the histological type and percentage of STI components.

Schlagwörter

Stichwörter der Autor:innen

differentiated high-grade thyroid carcinomafollicular thyroid carcinomapoorly differentiated thyroid carcinomaradioactive iodine treatment

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa 232-0024, Japan.
  • Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
  • Department of Pathology, Ito Hospital, Tokyo 150-8308, Japan.
  • Department of Surgery, Yokohama City University School of Medicine, Yokohama City, Kanagawa 236-0004, Japan.

ORCID-Profile: Haruhiko Yamazaki, Kiminori Sugino

Zitieren

APA

Yamazaki, H., Sugino, K., Katoh, R., Kawaida, M., Matsuzu, K., Kitagawa, W., Saito, A., & Ito, K. (2026). Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag120

Vancouver

Yamazaki H, Sugino K, Katoh R, Kawaida M, Matsuzu K, Kitagawa W, et al. Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag120

BibTeX
@article{Yamazaki2026,
  author = {Yamazaki, Haruhiko and Sugino, Kiminori and Katoh, Ryohei and Kawaida, Miho and Matsuzu, Kenichi and Kitagawa, Wataru and Saito, Aya and Ito, Koichi},
  title = {Relationship between histopathological findings and RAI in non-papillary follicular cell–derived thyroid carcinoma},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {7},
  doi = {10.1210/jendso/bvag120}
}
Kostenlos starten →